Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 1 , Pages 23-29 , July 2010

Uptake of dihomo-γ-linolenic acid by murine macrophages increases series-1 prostaglandin release following lipopolysaccharide treatment

Received 19 August 2009 ,Revised 3 February 2010 ,Accepted 22 February 2010.

References 

  1. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000;71:343S–348S
  2. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36:1007–1024
  3. Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 2004;23:281–302
  4. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet. 1978;2:117–119
  5. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000;69:145–182
  6. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871–1875
  7. Helliwell RJA, Adams LF, Mitchell MD. Prostaglandin synthase: recent developments and a novel hypothesis. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70:101–113
  8. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 1990;323:645–655
  9. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA. 2003;100:1751–1756
  10. Sinzinger H, Fitscha P, O'Grady J, Rauscha F, Rogatti W, Vane JR. Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. Lancet. 1990;335:627–628
  11. Whittle BJ, Moncada S, Vane JR. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins. 1978;16:373–388
  12. Kawashima H, Tateishi N, Shiraishi A, et al. Oral administration of dihomo-γ-linolenic acid prevents development of atopic dermatitis in NC/Nga mice. Lipids. 2008;43:37–43
  13. Takai S, Jin D, Kawashima H, et al. Anti-atherosclerotic effects of dihomo-γ-linolenic acid in apoE-deficient mice. J. Atheroscler. Thromb. 2009;16:480–489
  14. Shono F, Yokota K, Horie K, et al. A heterologous enzyme immunoassay of prostaglandin E2 using a stable enzyme-labeled hapten mimic. Anal. Biochem. 1988;168:284–291
  15. Hiroshima O, Hayashi H, Ito S, Hayaishi O. Basal level of prostaglandin D2 in rat brain by a solid-phase enzyme immunoassay. Prostaglandins. 1986;32:63–80
  16. Reinke M. Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. Am. J. Physiol. 1992;262:E658–E662
  17. Kempen EC, Yang P, Felix E, Madden T, Newman RA. Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Biochem. 2001;297:183–190
  18. Kita Y, Takahashi T, Uozumi N, Shimizu T. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography–tandem mass spectrometry. Anal. Biochem. 2005;342:134–143
  19. Hishinuma T, Suzuki K, Saito M, et al. Simultaneous quantification of seven prostanoids using liquid chromatography/tandem mass spectrometry: the effects of arachidonic acid on prostanoid production in mouse bone marrow-derived mast cells. Prostaglandins Leukot. Essent. Fatty Acids. 2007;76:321–329
  20. Masoodi M, Nicolaou A. Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006;20:3023–3029
  21. Matsumoto H, Naraba H, Murakami M, et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 1997;230:110–114
  22. Lee SH, Soyoola E, Chanmugam P, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 1992;267:25934–25938
  23. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 2005;338:70–76
  24. Levin G, Duffin KL, Obukowicz MG, et al. Differential metabolism of dihomo-γ-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem. J. 2002;365:489–496
  25. Wada M, DeLong CJ, Hong YH, et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 2007;282:22254–22266
  26. Yuan C, Sidhu RS, Kuklev DV, et al. Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase homodimers. J. Biol. Chem. 2009;284:10046–10055
  27. Cipollone F, Fazia M, Iezzi A, et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler. Thromb. Vasc. Biol. 2004;24:1259–1265
  28. Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br. J. Dermatol. 1989;121:75–90

PII: S0952-3278(10)00076-1

doi: 10.1016/j.plefa.2010.02.032

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 83, Issue 1 , Pages 23-29 , July 2010

Article Tools

* Image Usage & Resolution